Zurich Cantonal Bank
ALXO icon

Zurich Cantonal Bank’s ALX Oncology ALXO Stock Holding History

Zurich Cantonal Bank’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-237
Closed -$396 – 2629
2024
Q4 		$396 Sell
237
-1,007
-81% -$1.55K ﹤0.01% 2633
2024
Q3 		$2.26K Sell
1,244
-5,273
-81% -$19.6K ﹤0.01% 2639
2024
Q2 		$39.3K Buy
6,517
+5,200
+395% +$63.9K ﹤0.01% 2563
2024
Q1 		$14.7K Sell
1,317
-590
-31% -$8.29K ﹤0.01% 2645
2023
Q4 		$28.4K Buy
+1,907
New +$18.1K ﹤0.01% 2641
2023
Q2 		– Sell
-1,501
Closed -$6.79K – 2801
2023
Q1 		$6.79K Hold
1,501
– – ﹤0.01% 2809
2022
Q4 		$16.9K Sell
1,501
-3,733
-71% -$41.9K ﹤0.01% 2773
2022
Q3 		$50K Buy
+5,234
New +$61K ﹤0.01% 2589
2022
Q1 		– Sell
-611
Closed -$13K – 2722
2021
Q4 		$13K Sell
611
-64
-9% -$2.76K ﹤0.01% 2884
2021
Q3 		$50K Buy
675
+5
+0.7% +$333 ﹤0.01% 2608
2021
Q2 		$37K Hold
670
– – ﹤0.01% 2511
2021
Q1 		$49K Buy
+670
New +$52.7K ﹤0.01% 2392

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zurich Cantonal Bank's ALXO Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of ALX Oncology (ALXO) in Q1 2025, closing a stake of 237 shares — an estimated $396 sold.

Zurich Cantonal Bank first reported a position in ALXO in Q1 2021 and held it in 12 quarters. The position peaked at $50K in Q3 2022. 85 funds tracked by Wall St. Rank hold ALXO as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining ALX Oncology position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 237 ALX Oncology shares in Q1 2025, an estimated $396.
  • Zurich Cantonal Bank first reported a position in ALX Oncology in Q1 2021 and held it in 12 quarters.
  • Zurich Cantonal Bank's ALX Oncology position peaked at $50K in Q3 2022.
  • 85 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.